These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 29970741

  • 1. Early initiation of angiotensin-converting enzyme inhibitors in postrenal transplant period: A study from a state-run tertiary care center.
    Sreeadhara CG, Narayanaswamy R, Lingaraju U, Leelavathi V, Shivaprasad SM.
    Saudi J Kidney Dis Transpl; 2018; 29(3):637-642. PubMed ID: 29970741
    [Abstract] [Full Text] [Related]

  • 2. ACE inhibitors and angiotensin II antagonists in renal transplantation: an analysis of safety and efficacy.
    Stigant CE, Cohen J, Vivera M, Zaltzman JS.
    Am J Kidney Dis; 2000 Jan; 35(1):58-63. PubMed ID: 10620545
    [Abstract] [Full Text] [Related]

  • 3. Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the early period after kidney transplantation.
    Orlić L, Mikolasević I, Sladoje-Martinović B, Bubić I, Pavletić-Persić M, Racki S.
    Coll Antropol; 2013 Sep; 37(3):809-14. PubMed ID: 24308221
    [Abstract] [Full Text] [Related]

  • 4. Angiotensin converting enzyme inhibitor use soon after renal transplantation: a randomized, double-blinded placebo-controlled safety study.
    Glicklich D, Gordillo R, Supe K, Tapia R, Woroniecki R, Solorzano C, Coco M.
    Clin Transplant; 2011 Sep; 25(6):843-8. PubMed ID: 21158922
    [Abstract] [Full Text] [Related]

  • 5. Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern?
    Bakris GL, Weir MR.
    Arch Intern Med; 2000 Mar 13; 160(5):685-93. PubMed ID: 10724055
    [Abstract] [Full Text] [Related]

  • 6. Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation.
    Heinze G, Mitterbauer C, Regele H, Kramar R, Winkelmayer WC, Curhan GC, Oberbauer R.
    J Am Soc Nephrol; 2006 Mar 13; 17(3):889-99. PubMed ID: 16481415
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cardiovascular death in kidney recipients treated with renin-angiotensin system blockers.
    Opelz G, Döhler B.
    Transplantation; 2014 Feb 15; 97(3):310-5. PubMed ID: 24492421
    [Abstract] [Full Text] [Related]

  • 12. ACE-inhibitor or AT2-antagonist therapy of renal transplant recipients is associated with an increase in serum potassium concentrations.
    Mitterbauer C, Heinze G, Kainz A, Kramar R, Hörl WH, Oberbauer R.
    Nephrol Dial Transplant; 2008 May 15; 23(5):1742-6. PubMed ID: 18234845
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Use of angiotensin-converting enzyme inhibitors in patients with heart failure and renal insufficiency: how concerned should we be by the rise in serum creatinine?
    Ahmed A.
    J Am Geriatr Soc; 2002 Jul 15; 50(7):1297-300. PubMed ID: 12133029
    [Abstract] [Full Text] [Related]

  • 15. A prospective, randomized, open labeled crossover trial of fosinopril and theophylline in post renal transplant erythrocytosis.
    Trivedi H, Lal SM.
    Ren Fail; 2003 Jan 15; 25(1):77-86. PubMed ID: 12617335
    [Abstract] [Full Text] [Related]

  • 16. Renal allograft protection with early angiotensin-converting enzyme inhibitors administration.
    Montanaro D, Gropuzzo M, Tulissi P, Boscutti G, Mioni R, Risaliti A, Baccarani U, Adani GL, Sainz M, Bresadola F, Mioni G.
    Transplant Proc; 2004 Apr 15; 36(3):692-4. PubMed ID: 15110633
    [Abstract] [Full Text] [Related]

  • 17. Long-term therapy for postrenal transplant erythrocytosis with ACE inhibitors: efficacy, safety and action mechanisms.
    Montanaro D, Groupuzzo M, Boscutti G, Risaliti A, Bresadola F, Mioni G.
    Clin Nephrol; 2000 Apr 15; 53(4):suppl 47-51. PubMed ID: 10809436
    [Abstract] [Full Text] [Related]

  • 18. Angiotensin-converting enzyme inhibitors after renal transplantation.
    Bravo P, Felgueiras J, Santos C, Oliveira C, Ponce P.
    Transplant Proc; 2008 Apr 15; 40(3):740-2. PubMed ID: 18455003
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.